Skip to content

GILD

Gilead Sciences, Inc.

Free cash flow, 2025
$9.5B
YoY, 2025
−8.2%
5-year CAGR
+4.7%

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025$9.5B−8.2%
2024$10.3B+38.9%
2023$7.4B−11.1%
2022$8.3B−22.8%
2021$10.8B+43.7%
2020$7.5B−9.6%
2019$8.3B+11.3%
2018$7.5B—
2013$3.0B—